The Oncology Institute, Inc. (TOI) DCF Valuation

The Oncology Institute, Inc. (TOI) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

The Oncology Institute, Inc. (TOI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true value of The Oncology Institute, Inc. (TOI) with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how changes affect The Oncology Institute's valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 155.4 187.5 203.0 252.5 324.2 390.5 470.2 566.3 682.0 821.3
Revenue Growth, % 0 20.66 8.26 24.37 28.42 20.43 20.43 20.43 20.43 20.43
EBITDA .3 -11.3 -7.9 8.4 -70.5 -22.0 -26.5 -31.9 -38.4 -46.2
EBITDA, % 0.19762 -6.02 -3.91 3.33 -21.73 -5.63 -5.63 -5.63 -5.63 -5.63
Depreciation 2.9 3.2 3.3 4.4 5.9 6.9 8.3 10.0 12.0 14.4
Depreciation, % 1.89 1.69 1.65 1.75 1.81 1.76 1.76 1.76 1.76 1.76
EBIT -2.6 -14.5 -11.3 4.0 -76.3 -28.8 -34.7 -41.8 -50.4 -60.7
EBIT, % -1.7 -7.72 -5.56 1.58 -23.54 -7.39 -7.39 -7.39 -7.39 -7.39
Total Cash 2.4 6.0 114.3 73.8 82.9 90.5 109.0 131.2 158.0 190.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 14.7 17.3 21.2 40.4 42.9
Account Receivables, % 9.48 9.2 10.46 16.01 13.23
Inventories 3.9 4.4 6.4 9.3 13.7 12.4 14.9 18.0 21.7 26.1
Inventories, % 2.5 2.32 3.17 3.67 4.22 3.18 3.18 3.18 3.18 3.18
Accounts Payable 8.9 12.6 15.6 9.4 14.4 22.1 26.6 32.0 38.6 46.5
Accounts Payable, % 5.72 6.74 7.66 3.71 4.45 5.66 5.66 5.66 5.66 5.66
Capital Expenditure -1.2 -1.2 -3.0 -5.5 -4.6 -5.1 -6.1 -7.4 -8.9 -10.7
Capital Expenditure, % -0.77511 -0.63681 -1.5 -2.19 -1.41 -1.3 -1.3 -1.3 -1.3 -1.3
Tax Rate, % 0.04331921 0.04331921 0.04331921 0.04331921 0.04331921 0.04331921 0.04331921 0.04331921 0.04331921 0.04331921
EBITAT -4.0 -14.0 -10.6 3.5 -76.3 -27.6 -33.2 -40.0 -48.1 -58.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -12.0 -11.2 -13.5 -25.8 -76.8 -19.5 -38.4 -46.2 -55.7 -67.0
WACC, % 5.94 5.78 5.67 5.32 5.94 5.73 5.73 5.73 5.73 5.73
PV UFCF
SUM PV UFCF -187.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -68
Terminal Value -1,833
Present Terminal Value -1,388
Enterprise Value -1,575
Net Debt 86
Equity Value -1,661
Diluted Shares Outstanding, MM 74
Equity Value Per Share -22.52

What You Will Get

  • Comprehensive TOI Financials: Access to both historical and projected data for precise valuation.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Planning: Explore various scenarios to assess The Oncology Institute’s future performance.
  • User-Friendly Interface: Designed for industry professionals while remaining approachable for newcomers.

Key Features

  • Customizable Treatment Parameters: Adjust essential factors such as patient demographics, treatment efficacy, and cost of care.
  • Instant Outcome Projections: Provides real-time estimates of patient outcomes and cost-effectiveness.
  • High-Precision Analytics: Leverages TOI’s extensive clinical data for accurate treatment evaluations.
  • Seamless Scenario Testing: Explore various treatment pathways and easily compare results.
  • Efficiency-Boosting Solution: Streamlines the process of developing complex treatment models.

How It Works

  1. Step 1: Download the Excel file for The Oncology Institute, Inc. (TOI).
  2. Step 2: Review TOI’s pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as patient growth, treatment costs, and reimbursement rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for informed investment decisions.

Why Choose The Oncology Institute, Inc. (TOI) Calculator?

  • Comprehensive Tool: Integrates treatment cost analysis, patient outcome metrics, and financial projections in one solution.
  • Customizable Inputs: Modify highlighted fields to explore different treatment scenarios and financial outcomes.
  • Detailed Insights: Automatically computes the intrinsic value of TOI and forecasts future profitability.
  • Preloaded Data: Access to historical treatment data and market trends for informed decision-making.
  • Professional Quality: Perfect for healthcare analysts, investors, and oncology consultants.

Who Should Utilize This Service?

  • Healthcare Professionals: Enhance patient care with advanced oncology treatment solutions.
  • Researchers: Access valuable data and insights for groundbreaking cancer studies.
  • Patients and Families: Find comprehensive support and resources tailored to your oncology needs.
  • Healthcare Administrators: Streamline operations with efficient management tools designed for oncology practices.
  • Students and Educators: Utilize it as a resource for learning about oncology and cancer care methodologies.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for The Oncology Institute, Inc. (TOI).
  • Real-World Data: The Oncology Institute’s historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to The Oncology Institute, Inc. (TOI).
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.

No products were found matching.